Pharmaceutical Biotechnology Research group
HAKBABA-LAB
Ege University, Faculty of Pharmacy, Department of Pharmaceutical Biotechnology, Izmir/TURKEY.
RESEARCH OVERVIEW
Our team particularly focused on the development of functional nanoparticles for the delivery of nucleic acids and biotechnological drugs. Our main areas of interest are the use of microfluidic systems, DNA vaccines and immunotherapy approaches in cancer treatment. We also serve the production of various enzymes and proteins.
gene delivery
Non-viral gene delivery systems, lipid nanoparticles, and microfluidic droplet generation
vaccines
DNA and mRNA vaccines against infectious diseases and cancer vaccines
immunotherapeutics
Immunotherapeutics, T-cell therapy approaches and immune checkpoint gene knock-out via CRISPR tech
Hakbaba laboratory is a young and dynamic team. Our main goal is to service the non-viral gene delivery systems and gene therapy approaches to the humanity. We aim to develop an interdisciplinary approach in attempts to turn fundamental scientific discoveries into gene and biotech products. To this end, we welcome young scientists like us who have embraced Atatürk’s principles and revolutions, and diverse international talents as well. We are enthusiastic about new ideas, projects and collaborations.
hASAN aKBABA
Ph.D., Associate Prof. of Pharmaceutical Biotechnology, PI
Merve Nur Düzgün, HAK, Taha Berke Uysaler, Melike Özder, Deniz Onan, Shahrzad Mirbaha (left to the right)
Current members of
hakbaba-Lab 2023-2024
contact us
We are open to communication on any subject. Although e-mail is preferred, you can also write directly on the web.
akbabahasan@gmail.com